Brain Stimulation and Cognitive Training
Neuromodulation Plus Cognitive Training to Improve Working Memory Among Individuals With Serious Mental Illness.
1 other identifier
interventional
12
1 country
1
Brief Summary
People with serious mental illness often report difficulties with thinking skills like memory. These difficulties can make it harder to perform day-to-day activities. The purpose of this study is to test whether combining a type of non-invasive brain stimulation with computerized cognitive exercises is acceptable to participants, and whether it is helpful in improving a specific type of memory skill in people who have mental health conditions and memory deficits. This study is designed so that all participants will get both treatments: the non-invasive brain stimulation and computerized cognitive exercises. Half of the participants will start with both the brain stimulation and the cognitive exercises (dual therapy), and half will start with just the computerized exercises (monotherapy). After three weeks, participants will switch to the other condition: the people who did both treatments first will switch to just the cognitive exercises alone, and the people who started with the cognitive exercises alone will then switch to doing both the brain stimulation and cognitive exercises. Overall, participants will be in the study for about 7-8 weeks. The brain stimulation treatment involves 10 visits to the clinic over 3 weeks. The computerized cognitive exercises can be done at home, and involve 10 hours of exercises over 3 weeks. Participants will also complete paper-and-pencil assessments at the beginning, middle, and end of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2017
CompletedFirst Posted
Study publicly available on registry
November 9, 2017
CompletedStudy Start
First participant enrolled
October 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2019
CompletedResults Posted
Study results publicly available
September 2, 2020
CompletedSeptember 2, 2020
August 1, 2020
12 months
November 6, 2017
August 14, 2020
August 14, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Participant Retention in Combination Treatment
Number of participants completing every session of the combined phase of treatment
4 weeks
Participant-rated Acceptability of Combination Therapy
Self-reported satisfaction as indicated on a numerical rating scale (1-10, where higher scores indicate greater satisfaction)
8 weeks
Study Arms (2)
Dual Therapy First
EXPERIMENTALParticipants receive 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises (BrainHQ), followed by 10 hours of computerized cognitive exercises alone
Mono Therapy First
EXPERIMENTALParticipants complete 10 hours of computerized cognitive exercises (BrainHQ) alone, followed by 10 sessions of non-invasive brain stimulation (tDCS) plus 10 hours of computerized cognitive exercises
Interventions
tDCS is a non-invasive procedure in which electrodes are attached to the scalp and send a small direct current to stimulate brain function
BrainHQ is a web-based, commercially available cognitive training program that includes exercises to enhance working memory
Eligibility Criteria
You may qualify if:
- Diagnosis of bipolar disorder I or II, schizoaffective disorder, or schizophrenia
- Objective cognitive impairment in working memory
- Willingness to complete computerized cognitive training and undergo brain stimulation procedures
You may not qualify if:
- History of neurological illness or brain injury (e.g., stroke)
- History of loss of consciousness
- Diagnosed intellectual disability
- Current substance use disorder
- Current mania or moderate depression or severe psychosis
- Serious suicidal ideation/behavior
- Pregnant or trying to become pregnant, or currently lactating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Cynthia Burton
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia Burton, PhD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Lecturer, Department of Psychiatry
Study Record Dates
First Submitted
November 6, 2017
First Posted
November 9, 2017
Study Start
October 11, 2018
Primary Completion
September 27, 2019
Study Completion
September 27, 2019
Last Updated
September 2, 2020
Results First Posted
September 2, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share